Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial

BACKGROUND: We aimed to assess 24-month outcomes of wearing an organic light-emitting sleep mask as an intervention to treat and prevent progression of non-central diabetic macular oedema. METHODS: CLEOPATRA was a phase 3, single-blind, parallel-group, randomised controlled trial undertaken at 15 op...

Full description

Saved in:
Bibliographic Details
Published in:Lancet Diabetes Endocrinol
Main Authors: Sivaprasad, Sobha, Vasconcelos, Joana C, Prevost, A Toby, Holmes, Helen, Hykin, Philip, George, Sheena, Murphy, Caroline, Kelly, Joanna, Arden, Geoffrey B
Format: Artigo
Language:Inglês
Published: The Lancet, Diabetes & Endocrinology 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5908782/
https://ncbi.nlm.nih.gov/pubmed/29519744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(18)30036-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items